术前高剂量阿托伐他汀负荷对急性冠脉综合征患者PCI术后肾功能的影响

被引:2
作者
牟英
罗彩东
刘云兵
机构
[1] 绵阳市中心医院心脏中心
关键词
急性冠脉综合征; 冠脉介入治疗; 他汀强化; 肾功能;
D O I
10.16252/j.cnki.issn1004-0501-2013.11.033
中图分类号
R541.4 [冠状动脉(粥样)硬化性心脏病(冠心病)];
学科分类号
1002 ; 100201 ;
摘要
目的观察术前高剂量阿托伐他汀负荷对急性冠脉综合征(ACS)患者PCI术后肾功能的影响。方法择期PCI介入治疗的118例ACS患者随机分为两组:高剂量负荷组术前12h予阿托伐他汀40mg口服,术前2h再给予40mg口服,术后继续20mg/d治疗;对照组术前不予阿托伐他汀,仅术后予阿托伐他汀20mg/d治疗。测定PCI前后患者血肌酐(Scr)、尿素氮(BUN)、肌钙蛋白I(cTnI)、肌酸激酶同工酶(CK-MB)、血清C反应蛋白(CRP)水平,观察并比较两组患者造影剂肾病(CIN)的发生率,以及心肌损伤标志物、炎症指标变化。结果高剂量负荷组患者CIN发生率为1.69%,明显低于对照组11.86%(P<0.05)。PCI术后两组患者cTnI、CK-MB和CRP水平均较术前有明显增高(P<0.05),但高剂量负荷组明显低于对照组(P<0.05)。结论 PCI术前高剂量阿托伐他汀负荷可减少ACS患者术后CIN发生率,该保护效应可能与其减轻围手术期心肌损伤和炎症反应有关。
引用
收藏
页码:1690 / 1691
页数:2
相关论文
共 4 条
[1]  
Statin effects beyond lipid lowering-are they clinically relevant. Bonetti PO,Lerman LO,Napoli C,et al. European Heart Journal . 2003
[2]   Statin-induced expression of decay-accelerating factor protects vascular endothelium against complement-mediated injury [J].
Mason, JC ;
Ahmed, Z ;
Mankoff, R ;
Lidington, EA ;
Ahmad, S ;
Bhatia, V ;
Kinderlerer, A ;
Randi, AM ;
Haskard, DO .
CIRCULATION RESEARCH, 2002, 91 (08) :696-703
[3]  
2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/ Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines[J] . R. Scott Wright,Jeffrey L. Anderson,Cynthia D. Adams,Charles R. Bridges,Donald E. Casey,Steven M. Ettinger,Francis M. Fesmire,Theodore G. Ganiats,Hani Jneid,A. Michael Lincoff,Eric D. Peterson,George J. Phi
[4]  
Contrast-induced nephropathy--a review of current literature and guidelines. Maliborski Artur,Zukowski Pawe?,Nowicki Grzegorz,Bogus?awska Romana. Medical science monitor : international medical journal of experimental and clinical research . 2011